Your browser is no longer supported. Please, upgrade your browser.
SONN Sonnet BioTherapeutics Holdings, Inc. daily Stock Chart
Sonnet BioTherapeutics Holdings, Inc.
Index- P/E- EPS (ttm)-54.99 Insider Own9.40% Shs Outstand6.52M Perf Week31.64%
Market Cap23.60M Forward P/E- EPS next Y-0.93 Insider Trans0.00% Shs Float1.33M Perf Month2.84%
Income-17.20M PEG- EPS next Q- Inst Own0.50% Short Float41.81% Perf Quarter-24.43%
Sales28.00M P/S0.84 EPS this Y-23.90% Inst Trans- Short Ratio0.21 Perf Half Y-76.20%
Book/sh-8.73 P/B- EPS next Y- ROA- Target Price7.00 Perf Year-81.19%
Cash/sh0.08 P/C47.20 EPS next 5Y- ROE- 52W Range2.52 - 54.60 Perf YTD-76.40%
Dividend- P/FCF- EPS past 5Y22.30% ROI-436.50% 52W High-93.87% Beta1.11
Dividend %- Quick Ratio0.10 Sales past 5Y0.20% Gross Margin6.80% 52W Low32.74% ATR0.64
Employees587 Current Ratio0.10 Sales Q/Q-26.90% Oper. Margin- RSI (14)48.98 Volatility35.25% 15.40%
OptionableNo Debt/Eq- EPS Q/Q67.70% Profit Margin- Rel Volume0.65 Prev Close3.62
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume2.69M Price3.35
Recom2.00 SMA203.67% SMA50-8.45% SMA200-69.80% Volume1,588,217 Change-7.60%
Aug-04-20 07:35AM  
Jul-20-20 07:30AM  
Jul-15-20 07:30AM  
May-18-20 07:30AM  
Apr-06-20 07:30AM  
SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.